FRANKFURT (Reuters) – The CEO of Roche said more cases of mpox infection have likely occurred in Europe than previously reported and that the group could quickly offer 10 times more test kits than are currently in demand.
“It seems like there are more mpox cases already in Europe, maybe not all of them are in the media yet,” CEO Thomas Schinecker said in a media call after the Swiss drugs and diagnostics company reported quarterly sales.
(Reporting by Ludwig Burger, Editing by Rachel More)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.